Low on-treatment blood pressure and cardiovascular events in patients without elevated risk: a nationwide cohort study

Yuichiro Mori, Atsushi Mizuno, Shingo FukumaHypertension Research 2024 · DOI

TL;DR

This study investigated the potential harms of too low blood pressure in low-risk hypertensive patients, finding that very low diastolic blood pressure (<60 mmHg) was linked to increased cardiovascular events, while low systolic blood pressure (<110 mmHg) was not. These findings suggest that for low-risk individuals, focusing on maintaining adequate diastolic pressure might be more critical than aggressively lowering systolic pressure, contrasting with previous observations in high-risk populations.

What Problem Does This Paper Address?

Globally, many patients with hypertension are not adequately controlled, leading to a focus on intensifying treatment. However, there's a growing concern about the potential risks of overly aggressive blood pressure lowering, particularly in patients who are already at low risk for cardiovascular disease (CVD). Previous research has hinted at a "J-curve" phenomenon, where very low blood pressure might paradoxically increase CVD risk, but this has primarily been studied in high-risk patient groups. This paper aims to fill the evidence gap by examining this relationship specifically in a large cohort of low-risk, working-age individuals with hypertension.

Methods

The researchers conducted a nationwide, longitudinal observational study using administrative and medical record data. They identified a cohort of working-age individuals (40-74 years) who were continuously using antihypertensive drugs and had a 10-year atherosclerotic cardiovascular disease (ASCVD) risk of less than 10%. Participants were categorized based on their on-treatment systolic blood pressure (SBP) and diastolic blood pressure (DBP) measured at baseline. The primary outcome was a composite of major adverse cardiovascular events (MACE), including myocardial infarction, stroke, heart failure hospitalization, and peripheral artery disease. A Cox proportional hazards model was used to analyze the association between blood pressure categories and these outcomes, adjusting for various potential confounders. Sensitivity and subgroup analyses were performed to ensure the robustness of the findings.

Datasets

The study utilized data from the Japan Health Insurance Association, a large public health insurer covering over 30 million individuals. This dataset comprises claims data and annual health check-up records, providing a rich source of information on a nationally representative working-age population in Japan. The data included blood pressure measurements, laboratory test results, and self-reported medical and behavioral information.

Key Insights and Ideas

  • Diastolic Pressure is Key for Low-Risk Groups: The most striking finding is that very low diastolic blood pressure (<60 mmHg) was associated with an increased risk of cardiovascular events in low-risk patients, while low systolic blood pressure (<110 mmHg) did not show this association. This suggests that for this specific population, maintaining adequate diastolic pressure might be more crucial than aggressively lowering systolic pressure.
  • Contrast with High-Risk Populations: The results differ from previous studies on high-risk patients, where low SBP (<120 mmHg) was also linked to increased risk. This implies that low-risk individuals may tolerate lower SBP levels better, potentially due to different underlying physiological mechanisms or a lower overall burden of cardiovascular disease.
  • Potential Mechanism: Diastolic Flow: The authors hypothesize that the J-curve phenomenon, particularly for diastolic pressure, might be related to reduced diastolic blood flow in the coronary arteries. This is a known concern, and its impact might be more pronounced when overall cardiovascular risk is lower.
  • Asian Population Consideration: The paper notes that stroke is a more prevalent cardiovascular event in Asian populations compared to heart attacks. This insight, combined with their findings, suggests that physicians in Asia might be able to optimize blood pressure control more aggressively in low-risk patients, with a focus on avoiding critically low diastolic pressures.

Key Results

  • A cohort of 920,533 low-risk hypertensive patients was analyzed.
  • Diastolic Blood Pressure: A DBP <60 mmHg was associated with a 25% increased risk of cardiovascular events (HR 1.25, 95% CI: 1.14–1.38). DBP of 90-99 mmHg was associated with a 13% increased risk (HR 1.13, 95% CI: 1.09–1.18), and ≥100 mmHg with a 66% increased risk (HR 1.66, 95% CI: 1.58–1.76).
  • Systolic Blood Pressure: SBP <110 mmHg was not significantly associated with an increased risk of cardiovascular events (HR 1.05, 95% CI: 0.99–1.12). However, higher SBP levels (≥140 mmHg) were associated with increased risk, as expected.
  • Only about 1.5% of the cohort had DBP <60 mmHg, suggesting that the number of patients at risk due to excessive BP reduction was relatively small.

Limitations and Future Work

The authors acknowledge several limitations:

  • Reverse Causality: Despite efforts to mitigate it (e.g., selecting prevalent users of antihypertensives), there's a possibility that patients with declining health status might have been classified into low BP categories.
  • BP Measurement Frequency: The use of only two annual health check-ups might lead to misclassification of BP categories.
  • White-Coat Effect: Casual BP measurements in a clinical setting can be influenced by the "white-coat effect."
  • Lack of Race/Ethnicity Data: While the cohort is assumed to be Asian, specific race/ethnicity data was not available.
  • Drug Class Information: The study did not account for the specific classes of antihypertensive drugs used.

Future work could focus on:

  • External Validity: Investigating these findings in populations with different social backgrounds.
  • Treatment Regimens: Exploring how different treatment strategies influence outcomes.
  • Clinical Trials: Designing trials that compare blood pressure control strategies with varied targets specifically for low-risk patients.
  • Asian Population Focus: Further research to guide physicians in Asia on safely optimizing BP control in low-risk patients, considering the higher prevalence of stroke.

Summary updated

Abstract

Insufficient blood pressure control among patients with hypertension without elevated risk is a global concern, suggesting the need for treatment optimization. However, the potential harm of excessive blood pressure lowering among these patients is understudied. This study addressed this evidence gap by using nationally representative public health insurer database covering 30 million working-age population. Patients who were continuously using antihypertensive drugs with 10-year cardiovascular risk <10% were identified. They were categorized by on-treatment systolic and diastolic blood pressures. The primary outcome was a composite of myocardial infarction, stroke, heart failure hospitalization, and peripheral artery disease. Of 920,533 participants (mean age, 57.3 years; female, 48.3%; mean follow-up, 2.75 years), the adjusted hazard ratios for systolic blood pressure of <110, 110-119, 120-129 (reference), 130-139, 140-149, 150-159, and ≥160 mmHg were 1.05 (95% confidence interval: 0.99-1.12), 0.97 (0.93-1.02), 1 (reference), 1.05 (1.01-1.09), 1.15 (1.11-1.20), 1.30 (1.23-1.37), and 1.76 (1.66-1.86), respectively; and for diastolic blood pressure of <60, 60-69, 70-79 (reference), 80-89, 90-99, and ≥100 mmHg were 1.25 (1.14-1.38), 0.99 (0.95-1.04), 1 (reference), 1.00 (0.96-1.03), 1.13 (1.09-1.18), and 1.66 (1.58-1.76), respectively. Among low-risk patients with hypertension, diastolic blood pressure <60 mmHg was associated with increased cardiovascular events, while systolic blood pressure <110 mmHg was not. Compared to previous investigations in high-risk patients, the potential harm of excessive blood pressure lowering was less pronounced in low-risk patients with hypertension. The association between low on-treatment blood pressure and cardiovascular events has been understudied in low-risk patients with hypertension. In our study with nationally representative working-age adults from general population with hypertension without elevated risk, increased risk of cardiovascular events was observed in diastolic blood pressure of <60 mmHg, but not in systolic blood pressure of <110 mmHg. Those results contrasted with previous investigations in high-risk patients where the risk of low on-treatment blood pressure was more pronounced.
BibTeX
@inproceedings{mori2024low,
  author = {Yuichiro Mori and Atsushi Mizuno and Shingo Fukuma},
  title = {{Low on-treatment blood pressure and cardiovascular events in patients without elevated risk: a nationwide cohort study}},
  booktitle = {Hypertension Research},
  year = {2024},
  doi = {10.1038/s41440-024-01593-y},
}
Figure